Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

FRX

Ferrex (FRX)

Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:FRX
DateTimeSourceHeadlineSymbolCompany
01/04/200612:38PMPR Newswire (US)Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2006 Third Quarter EarningsNYSE:FRXForest Road Acquisition Corp
11/28/20054:10PMPR Newswire (US)Gedeon Richter and Forest Laboratories Expand Relationship with Two New Collaborations for CNS CompoundsNYSE:FRXForest Road Acquisition Corp
10/26/20055:10PMPR Newswire (US)Forest Laboratories and H. Lundbeck A/S Announce Lexapro Patent Litigation Trial Date Rescheduled to March 15, 2006NYSE:FRXForest Road Acquisition Corp
10/18/200510:44AMPR Newswire (US)MORNING UPDATE: Seven Summits Research issues alerts for IBM, WFC, GENZ, FRX, and NVSNYSE:FRXForest Road Acquisition Corp
10/18/20059:15AMPR Newswire (US)Forest Laboratories Announces Executives Intend to Exercise Options With Intent to Hold SharesNYSE:FRXForest Road Acquisition Corp
10/18/20059:12AMPR Newswire (US)Forest Laboratories Reports Earnings Per Share of $0.59 for Q2'06NYSE:FRXForest Road Acquisition Corp
10/06/20059:01AMPR Newswire (US)Forest Laboratories and Lundbeck Enter Into Settlement Agreement With Alphapharm Related to Lexapro Patent LitigationNYSE:FRXForest Road Acquisition Corp
10/05/20055:06PMPR Newswire (US)Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2006 Second Quarter EarningsNYSE:FRXForest Road Acquisition Corp
09/28/20059:10PMPR Newswire (US)/C O R R E C T I O N -- Forest Laboratories, Inc.; Cypress Biosciences, Inc./NYSE:FRXForest Road Acquisition Corp
09/28/20055:51PMPR Newswire (US)Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Results of Phase III Study for Milnacipran as a Treatment for FiNYSE:FRXForest Road Acquisition Corp
08/26/20051:00PMPR Newswire (US)Forest Laboratories Updates Lexapro Patent Litigation StatusNYSE:FRXForest Road Acquisition Corp
08/18/20056:10PMPR Newswire (US)Oral Solution Formulation of Namenda(R), the Only FDA-Approved Oral Solution for Moderate to Severe Alzheimer's Disease, Now AvaNYSE:FRXForest Road Acquisition Corp
07/25/20051:31PMPR Newswire (US)Forest Laboratories Announces FDA Decision on Supplemental New Drug Application for Namenda(R)NYSE:FRXForest Road Acquisition Corp
07/20/200511:15AMPR Newswire (US)MORNING UPDATE: Mankus-Lavelle Group issues alerts for MOT, JNPR, MO, MEL, and FRXNYSE:FRXForest Road Acquisition Corp
07/19/20059:04AMPR Newswire (US)Forest Laboratories, Inc. Reports Fiscal First Quarter 2006 ResultsNYSE:FRXForest Road Acquisition Corp
07/14/20052:38PMPR Newswire (US)Forest Laboratories, Inc. to Continue Clinical Development of Neramexane Based on New Clinical Trial ResultsNYSE:FRXForest Road Acquisition Corp
07/11/20053:11PMPR Newswire (US)Forest Laboratories, Inc. Sets Date and Conference Call For Fiscal 2006 First Quarter EarningsNYSE:FRXForest Road Acquisition Corp
07/01/20059:05AMPR Newswire (US)Phillip M. Satow Resigns from Forest Laboratories Board of DirectorsNYSE:FRXForest Road Acquisition Corp
05/19/20059:57AMPR Newswire (US)Forest Laboratories, Inc. Names Ivan Gergel, M.D., Senior Vice-President and President of Forest Research InstituteNYSE:FRXForest Road Acquisition Corp
05/10/20055:30PMPR Newswire (US)Forest Laboratories, Inc. Announces New Share Repurchase ProgramNYSE:FRXForest Road Acquisition Corp
05/05/20058:51PMPR Newswire (US)Scott + Scott, LLC Client/Shareholder Filed Securities Lawsuit Against Forest Laboratories, Inc. - Lead Papers to be Filed on TuNYSE:FRXForest Road Acquisition Corp
04/28/20055:40PMPR Newswire (US)Forest Laboratories Announces Court Sets New Trial Date for Lexapro Patent ChallengeNYSE:FRXForest Road Acquisition Corp
04/19/200511:38AMPR Newswire (US)MORNING UPDATE: Man Securities Inc. Issues Alerts for TXN, ADBE, BSX, NWS, and FRXNYSE:FRXForest Road Acquisition Corp
04/19/20058:58AMPR Newswire (US)Forest Laboratories Reports Fiscal Fourth Quarter 2005 Results and Provides Earnings Per Share Guidance for Fiscal 2006NYSE:FRXForest Road Acquisition Corp
04/15/200510:00AMPR Newswire (US)Campral(R) is Safe and Well-Tolerated in Long-Term Treatment of Alcohol Dependence According to Results Presented at American SoNYSE:FRXForest Road Acquisition Corp
04/11/20051:56PMPR Newswire (US)Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2005 Fourth Quarter EarningsNYSE:FRXForest Road Acquisition Corp
04/06/20059:23AMPR Newswire (US)Forest Laboratories Issues Revised Estimate for Q4'05 Earnings Per ShareNYSE:FRXForest Road Acquisition Corp
03/30/20055:10PMPR Newswire (US)Forest Laboratories, Inc. Receives Non-Approvable Letter for Social Anxiety Disorder Indication for Lexapro(R)NYSE:FRXForest Road Acquisition Corp
03/21/20059:24AMPR Newswire (US)MORNING UPDATE: Man Securities Inc. issues alerts for AIG, DRL, ADBE, SPLS, and FRXNYSE:FRXForest Road Acquisition Corp
03/21/20058:05AMPR Newswire (US)New COMBUNOX(TM) (Oxycodone HCl and Ibuprofen) Tablets (CII) Now Available for the Short-Term Treatment of Acute, Moderate to SeNYSE:FRXForest Road Acquisition Corp
 Showing the most relevant articles for your search:NYSE:FRX

Your Recent History

Delayed Upgrade Clock